← back to search

Dániel Aradi

LMU Klinikum ·
Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Medicine, Prasugrel, Percutaneous coronary intervention, Clopidogrel, Ticagrelor, and Internal medicine.
h-index
citations
2,778
works
9
NIH funding
primary concept
email

Recent publications

The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
Thrombosis and Haemostasis 2020cited by 329position: middledoi
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
JACC: Cardiovascular Interventions 2019cited by 528position: middledoi
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients
European Heart Journal - Cardiovascular Pharmacotherapy 2019cited by 99position: middledoi
International Expert Consensus on Switching Platelet P2Y <sub>12</sub> Receptor–Inhibiting Therapies
Circulation 2017cited by 383position: middledoi
A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI
Thrombosis and Haemostasis 2016cited by 44position: middledoi
Bleeding and stent thrombosis on P2Y<sub>12</sub>-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention
European Heart Journal 2015cited by 357position: firstdoi
Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding
Journal of the American College of Cardiology 2013cited by 896position: middledoi
Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: Systematic review and meta-analysis
International Journal of Cardiology 2012cited by 138position: firstdoi
TCT-747 Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: Systematic review and meta-analysis
Journal of the American College of Cardiology 2012cited by 4position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Dirk Sibbing · LMU Klinikum6 papers (2012–2020) · 5 papers (2012–2017)Matthew J. Price · Scripps Clinic5 papers (2012–2017)Paul A. Gurbel · Sinai Hospital4 papers (2013–2020)Marco Valgimigli · Università della Svizzera italiana4 papers (2012–2017)Dominick J. Angiolillo · Policlinico Universitario di Catania4 papers (2013–2020)Dietmar Trenk · Universitäts-Herzzentrum Freiburg-Bad Krozingen4 papers (2012–2017)Udaya S. Tantry · Sinai Hospital4 papers (2013–2020)Dimitrios Alexopoulos · National and Kapodistrian University of Athens2 papers (2013–2017) · 2 papers (2012–2012)Jolanta M. Siller‐Matula · Medical University of Vienna2 papers (2013–2015) · 2 papers (2012–2012)Gregg W. Stone · Icahn School of Medicine at Mount Sinai2 papers (2013–2015) · 2 papers (2013–2020)Ajay J. Kirtane · Columbia University Irving Medical Center2 papers (2013–2015) · 2 papers (2013–2015)András Komócsi · LMU Klinikum2 papers (2012–2012)Tobias Geisler · Heart and Diabetes Center North Rhine-Westphalia2 papers (2013–2020)Thomas Cuisset · Aix-Marseille Université2 papers (2012–2017)Thomas Cuisset · Inserm2 papers (2012–2015)